Prof. Shimon Sakaguchi (Osaka University, Japan)
How shall we validate International GL of IPF 2018?
Pathogenesis and Basic Research
- How P. acnes associate to build up Sarcoidosis?
- Search for T cell epitopes in sarcoidosis
ILD diagnosis (radiology or biomarkers etc.)
- When will machines replace radiologists for diagnosis of ILDs
- What is the difference between interstitial lung abnormalities and IPF?
- How useful is Extracellular Matrix for evaluating Activity of ILD?
- Genetic Impact of Worsening Activity of UIP?
- How should we treat pulmonary sarcoidosis?
- FDG-PET for sarcoidosis –WASOG Task Force report
- What endpoints should be used for assessment of outcomes in sarcoidosis
- Genetics of pulmonary sarcoidosis?
IIPs/IPF diagnosis guideline (radiology or biomarkers etc.)
- How to interpret radiology aspects of the guidelines
- Why the new guidelines are appropriate: ATS Guidelines
- Limitations of the guidelines Fleischener
Management of IIPs/IPF
- Trend of IPF Treatment
- Treatment of NSIP
- Strategy for Acute Exacerbation of IPF
- How to manage comorbidities in IIPs?
IPF and Lung Cancer – A Neglected Problem or A call to Arms
- Epidemiology and Existing Data
- IPF and Lung Cancer Diagnosis and Management: A World Survey
- Common Pathogenetic Mechanisms
- Patients with IPF and lung cancer: A much needed consensus
Related and Rare Lung Diseases (CHP, CTD-ILD, LAM, PAP and pneumoconiosis etc.)
- IgG4-related lung disease
- New Entities: PPFE, SRIF, CPFE, ACIF